0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 141-160 of 522 Articles
Research Letter |  FREE
Simon Kessner; Katja Wiech, PhD; Katarina Forkmann, MS; et al.
JAMA Intern Med. 2013;173(15):1468-1469. doi:10.1001/jamainternmed.2013.6705.

Comment and Response | 
David L. Keller, MD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7747.

Comment and Response | 
David L. Keller, MD
JAMA Intern Med. 2013;173(15):1476. doi:10.1001/jamainternmed.2013.8147.

Comment and Response | 
Brian K. Alldredge, PharmD; Steven R. Kayser, PharmD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7701.

Comment and Response | 
Jie Jin Wang, MMed, PhD; Gerald Liew, MBBS, PhD; Paul Mitchell, MD, PhD
JAMA Intern Med. 2013;173(15):1476-1477. doi:10.1001/jamainternmed.2013.8131.

Original Investigation |  FREE
Mark A. Espeland, PhD; Sally A. Shumaker, PhD; Iris Leng, PhD, MD; et al.
JAMA Intern Med. 2013;173(15):1429-1436. doi:10.1001/jamainternmed.2013.7727.

Special Communication | 
Stephen R. Braun, BA
JAMA Intern Med. 2013;173(15):1458-1460. doi:10.1001/jamainternmed.2013.6892.

Invited Commentary | 
Kasia J. Lipska, MD, MHS; Victor M. Montori, MD
JAMA Intern Med. 2013;173(14):1306-1307. doi:10.1001/jamainternmed.2013.6189.

Comment and Response | 
L. John Hoffer, MD, PhD
JAMA Intern Med. 2013;173(14):1384. doi:10.1001/jamainternmed.2013.7731.

Comment and Response | 
Hans-Göran Tiselius, MD; Agneta Åkesson, PhD; Laura D. K. Thomas, MSc
JAMA Intern Med. 2013;173(14):1384a. doi:10.1001/jamainternmed.2013.7699.

Original Investigation |  FREE
Amit S. Chitnis, MD, MPH; Stacy M. Holzbauer, DVM, MPH; Ruth M. Belflower, RN, MPH; et al.
JAMA Intern Med. 2013;173(14):1359-1367. doi:10.1001/jamainternmed.2013.7056.
Includes: CME

Invited Commentary | 
Kent A. Sepkowitz, MD
JAMA Intern Med. 2013;173(14):1367-1368. doi:10.1001/jamainternmed.2013.7940.

Viewpoint | 
Gregory W. Daniel, PhD, MPH; Erin K. Rubens, MPH, MBA; Mark McClellan, MD, PhD
JAMA Intern Med. 2013;173(14):1281-1282. doi:10.1001/jamainternmed.2013.6793.

Original Investigation |  FREE
Ishak Mansi, MD; Christopher R. Frei, PharmD, MSc; Mary Jo Pugh, PhD; et al.
JAMA Intern Med. 2013;173(14):1318-1326. doi:10.1001/jamainternmed.2013.6184.
Includes: Supplemental Content

Research Letter |  FREE
Lilian M. Abbo, MD; Susan E. Beekmann, RN, MPH; Thomas M. Hooton, MD; et al.
JAMA Intern Med. 2013;173(14):1376-1378. doi:10.1001/jamainternmed.2013.6480.
Includes: Supplemental Content

Invited Commentary | 
Prescott G. Woodruff, MD, MPH
JAMA Intern Med. 2013;173(13):1184-1185. doi:10.1001/jamainternmed.2013.1201.

Research Letter |  FREE
Beverly B. Green, MD, MPH; Melissa L. Anderson, MS; James D. Ralston, MD, MPH; et al.
JAMA Intern Med. 2013;173(13):1250-1252. doi:10.1001/jamainternmed.2013.1037.
Includes: Supplemental Content

Original Investigation |  FREE
Andrea Gershon, MD, MS; Ruth Croxford, MSc, PStat; Andrew Calzavara, MSc; et al.
JAMA Intern Med. 2013;173(13):1175-1185. doi:10.1001/jamainternmed.2013.1016.

Viewpoint | 
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Intern Med. 2013;173(13):1169-1170. doi:10.1001/jamainternmed.2013.854.

Viewpoint | 
R. Alta Charo, JD
JAMA Intern Med. 2013;173(13):1165-1166. doi:10.1001/jamainternmed.2013.7161.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH